The prognostic significance of p53 expression in gastric cancer: a meta-analysis

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Cancer Research and Clinical Oncology

• Publication date

  2015-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00432-014-1844-7PMID 25316440PMCID PMC11823733
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epidemiology of Gastric Cancer

  2015cited by this paper
• Cyclooxygenase-2 Expression Is Associated with Poor Overall Survival of Patients with Gastric Cancer: A Meta-Analysis

  2014cited by this paper
• Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.

  2014cited by this paper
• New molecular staging with G-factor supplements TNM classification in gastric cancer: a multicenter collaborative research by the Japan Society for Gastroenterological Carcinogenesis G-Project committee

  2014cited by this paper
• Cancer statistics, 2014

  2014cited by this paper
• Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.

  2014cited by this paper
• The prognostic value of E‐cadherin in gastric cancer: A meta‐analysis

  2013cited by this paper
• ERCC1 predicts outcome in patients with gastric cancer treated with adjuvant cisplatin-based chemotherapy

  2013cited by this paper
• Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer

  2013cited by this paper
• The role of p53 on survival of upper urinary tract urothelial carcinoma: a systematic review and meta-analysis.

  2013cited by this paper
• Clinicopathological and prognostic significance of Ki-67, caspase-3 and p53 expression in gastric carcinomas

  2013cited by this paper
• A systematic review of p53 as a biomarker of survival in patients with osteosarcoma

  2013cited by this paper
• Relationship between expression of apoptosis-related proteins and the efficacy of postoperative chemotherapy in patients with T3 gastric cancer

  2012cited by this paper
• A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status.

  2012cited by this paper
• Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.

  2012cited by this paper
• Synergistic Role between p53 and JWA: Prognostic and Predictive Biomarkers in Gastric Cancer

  2012cited by this paper
• Prognostic value of expression of Kit67, p53, TopoIIa and GSTP1 for curatively resected advanced gastric cancer patients receiving adjuvant paclitaxel plus capecitabine chemotherapy.

  2012cited by this paper
• Keratin 17 Expression Correlates with Tumor Progression and Poor Prognosis in Gastric Adenocarcinoma

  2012cited by this paper
• Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis

  2012cited by this paper
• Global cancer statistics

  2011cited by this paper
• p53 and its mutants in tumor cell migration and invasion

  2011cited by this paper
• Advanced detection of recent changing trends in gastric cancer survival: up-to-date comparison by period analysis.

  2011cited by this paper
• p53 Status and Its Prognostic Role in Extrahepatic Bile Duct Cancer: A Meta-Analysis of Published Studies

  2011cited by this paper
• The immunohistochemical expression of the p53-protein in gastric carcinomas. Correlation with clinicopathological factors and survival of patients.

  2010cited by this paper
• A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis

  2009cited by this paper
• Adenocarcinoma of the esophagogastric junction: relationship between clinicopathological data and p53, cyclin D1 and Bcl-2 immunoexpressions.

  2009cited by this paper
• COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer

  2009cited by this paper
• Recent patterns in gastric cancer: A global overview

  2009cited by this paper
• Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma.

  2009cited by this paper
• The overexpression of c-met as a prognostic indicator for gastric carcinoma compared to p53 and p21 nuclear accumulation.

  2008cited by this paper
• Significance of genetic abnormalities of p53 protein in Slovenian patients with gastric carcinoma.

  2007cited by this paper
• Clinicopathological and immunohistochemical markers after radical gastrectomy for gastric cancer.

  2007cited by this paper
• Chemotherapy of advanced gastric cancer.

  2007cited by this paper
• p53: Guardian of the Genome and Policeman of the Oncogenes

  2007cited by this paper
• Practical methods for incorporating summary time-to-event data into meta-analysis

  2007cited by this paper
• Regulating the p53 pathway: in vitro hypotheses, in vivo veritas

  2006cited by this paper
• Lack of prognostic impact of p53 gene mutation and p53 phosphorylation at serine 15 in multimodally treated adenocarcinomas of the gastroesophageal junction

  2006cited by this paper
• Molecular Markers for Gastric Adenocarcinoma

  2006cited by this paper
• Epidemiology of gastric cancer in Japan

  2005cited by this paper
• The p53 pathway and human cancer

  2005cited by this paper
• Combined Evaluation of Expressions of Cyclin E and p53 Proteins as Prognostic Factors for Patients with Gastric Cancer

  2005cited by this paper
• The prognostic significance of p53, p27kip1, p21waf1, HER‐2/neu, and Ki67 proteins expression in gastric cancer: A clinicopathological and immunohistochemical study of 121 Arab patients

  2005cited by this paper
• P53 as a prognostic marker for bladder cancer: a meta-analysis and review.

  2005cited by this paper
• Apoptotic and anti‐angiogenic strategies in liver and gastrointestinal malignancies

  2005cited by this paper
• Molecular markers in gastric cancer: can p53 and bcl-2 protein expressions be used as prognostic factors?

  2005cited by this paper
• p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer

  2004cited by this paper
• Prognostic Significance of TP53 Tumor Suppressor Gene Expression and Mutations in Human Osteosarcoma

  2004cited by this paper
• TP53 in gastric cancer: Mutations in the L3 loop and LSH motif DNA‐binding domains of TP53 predict poor outcome

  2004cited by this paper
• p53 Mutation Pattern and Expression of c-erbB2 and c-met in Gastric Cancer: Relation to Histological Subtypes, Helicobacter pylori Infection, and Prognosis

  2004cited by this paper
• Clinicopathological significance and survival influence of p53 protein expression in gastric carcinoma

  2004cited by this paper
• A dynamic role of HAUSP in the p53-Mdm2 pathway.

  2004cited by this paper
• Combined p53/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability

  2003cited by this paper
• Chromosomal instability rather than p53 mutation is associated with response to neoadjuvant cisplatin-based chemotherapy in gastric carcinoma.

  2003cited by this paper
• TP53 and gastric carcinoma: A review

  2003cited by this paper
• Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancer

  2003cited by this paper
• Gastric cancer epidemiology and risk factors.

  2003cited by this paper
• Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.

  2003cited by this paper
• The epidemiology of gastric cancer

  2002cited by this paper
• The Role of Vascular Endothelial Growth Factor (VEGF) and p53 Status for Angiogenesis in Gastric Cancer

  2002cited by this paper
• Overexpression of the c-met protooncogene in human gastric carcinoma--correlation to clinical features.

  2001cited by this paper
• Expression of p21(WAF1/CIP1) and p53 proteins in gastric carcinoma: its relationships with cell proliferation activity and prognosis.

  2001cited by this paper
• Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis.

  2001cited by this paper
• P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.

  2000cited by this paper
• The p53 Tumor Suppressor Gene: From Molecular Biology to Clinical Investigation

  2000cited by this paper
• Recurrence following curative resection for gastric carcinoma

  2000cited by this paper
• Loss of p27Kip1 expression is a strong independent prognostic factor of reduced survival in N0 gastric carcinomas

  2000cited by this paper
• Expression of p53 Protein and Prognosis in Gastric Carcinoma

  1999cited by this paper
• P53-protein accumulation and MDM2-protein overexpression in gastric carcinomas. No apparent correlation with survival.

  1999cited by this paper
• p53 Accumulation Is a Prognostic Factor in Intestinal-Type Gastric Carcinoma but Not in the Diffuse Type

  1999cited by this paper
• Prognostic value of p53 protein expression for patients with gastric cancer – a multivariate analysis

  1999cited by this paper
• Prognostic significance of different biological markers (DNA index, PCNA index, apoptosis, p53, karyotype) in 126 adenocarcinoma gastric biopsies.

  1998cited by this paper
• Overexpression of p53 predicts shorter survival in diffuse type gastric cancer

  1998cited by this paper
• Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints.

  1998cited by this paper
• Bias in meta-analysis detected by a simple, graphical test

  1997cited by this paper
• Barrett's esophagus. The significance of p53 in clinical practice.

  1997cited by this paper
• p53 accumulation and mutation are prognostic indicators of poor survival in human gastric carcinoma

  1996cited by this paper
• Implications of the p53 tumor-suppressor gene in clinical oncology.

  1995cited by this paper
• The relationship of p53 expression to the prognosis of 418 patients with gastric carcinoma

  1995cited by this paper
• An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms

  1994cited by this paper
• p53 mutations in human bladder cancer: Genotypic versus phenotypic patterns

  1994cited by this paper
• Operating characteristics of a rank correlation test for publication bias.

  1994cited by this paper
• The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma.

  1994cited by this paper
• Cancer. p53, guardian of the genome.

  1992cited by this paper
• p53, guardian of the genome

  1992cited by this paper
• Participation of p53 protein in the cellular response to DNA damage.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Publication bias : a problem in interpreting medical data

  1988cited by this paper
• THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

  1965cited by this paper

• Exploring the potential of machine learning in gastric cancer: prognostic biomarkers, subtyping, and stratification

  2025cites this paper
• A comprehensive analysis of the expression and prognostic significance of signal transducers and activators of transcription family in gastric cancer patients

  2024cites this paper
• Diagnostic, Prognostic, and Predictive Biomarkers in Gastric Cancer: from Conventional to Novel Biomarkers.

  2024cites this paper
• Redefining aberrant P53 expression of gastric cancer and its distinct clinical significance among molecular-histologic subtypes.

  2024cites this paper
• Mutant pattern of p53 predicts local recurrence and poor survival rate in gastric cancer.

  2023cites this paper
• Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors

  2023cites this paper
• Gastric cancer with microsatellite instability displays increased thymidylate synthase expression

  2022cites this paper
• Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma

  2022cites this paper
• 4-Methylumbelliferone administration enhances radiosensitivity of human fibrosarcoma by intercellular communication

  2021cites this paper
• Different effects of p53 protein overexpression on the survival of gastric cancer patients according to Lauren histologic classification: a retrospective study

  2021cites this paper
• Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished Affair

  2021cites this paper
• Clinical and pathological significance of proliferation index and p53 expression in gastric adenocarcinoma.

  2021cites this paper
• Deep muscularis propria tumor invasion without lymph node metastasis as a unique subclassification of stage IB gastric cancer: a retrospective study

  2021cites this paper
• HER-2 positivity is a high risk of recurrence of stage I gastric cancer

  2020cites this paper
• Long noncoding RNA VCAN‐AS1 contributes to the progression of gastric cancer via regulating p53 expression

  2020cites this paper
• Prognostic Biomarkers for Gastric Cancer: An Umbrella Review of the Evidence

  2019cites this paper
• Clinical effects of p53 overexpression in squamous cell carcinoma of the sinonasal tract

  2017cites this paper
• Genomic landscape of gastric cancer: molecular classification and potential targets

  2016cites this paper
• Mechanisms of silencing TP53 in EBV - related neoplasias

  2016cites this paper
• Prognostic significance of p53 expression in patients with esophageal cancer: a meta-analysis

  2016cites this paper
• The HDM2 (MDM2) Inhibitor NVP-CGM097 Inhibits Tumor Cell Proliferation and Shows Additive Effects with 5-Fluorouracil on the p53-p21-Rb-E2F1 Cascade in the p53wild type Neuroendocrine Tumor Cell Line GOT1

  2016cites this paper
• The clinical translational potential of p53-related alterations as cancer biomarkers.

  2015cites this paper